[ Price : $8.95]
Researchers suggest 14 drugs that need to be studied for heavy off-label use without sufficient scientific evidence of effectivene...[ Price : $8.95]
FDA approves Johnson & Johnsons new moderate-to-severe pain reliever tapendatol immediate release tablets.[ Price : $8.95]
FDA extends by 90 days the PDUFA deadline for its review of Somaxons NDA for Silenor to treat insomnia.[ Price : $8.95]
FDA grants an orphan drug designation to Biovitrum AB and Syntonix Pharmaceuticals for their FIXFc compound, indicated for treatin...[ Price : $8.95]
Protherics submits to FDA the first element of its rolling BLA for Voraxaze, an agent to mitigate methotrexate toxicity.[ Price : $8.95]
Genzyme Corp. submits a supplemental NDA for Clolar (clofarabine) seeking approval in treating adult patients with acute myeloid l...[ Price : $8.95]
FDA has accepted for filing Dyax BLA for its DX-88 to treat acute hereditary angioedema attacks.[ Price : $8.95]
CSL Behring initiates a field correction on five lots of its Component Pack packaged with Mononine (Coagulation Factor IX, Human).